Premium
The Treatment of Oestrogen‐Escaped Carcionoma of the Prostate with Estramustine Phosphate
Author(s) -
CHISHOLM G. D.,
O'DONOGUE E. P. N.,
KENNEDY C. L.
Publication year - 1977
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1977.tb04559.x
Subject(s) - estramustine , prostate , prostate cancer , medicine , oncology , prostate carcinoma , cancer , urology , gynecology , prostate disease
30 patients with oestrogen-escaped carcinoma of the prostate have been treated with estramustine phosphate (Estracyt). 27% showed a partial objective response and 33% had a subjective response. The terms used for defining a response are challenged and it is recommended that comparative controlled trials are necessary to judge the place of this drug in the management of advanced prostatic cancer.